XTNT

Xtant Medical Holdings Inc.

AMEX

Add Alert

XTNT

Xtant Medical Holdings Inc.

AMEX

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

$Pistol Pete$ Free

04/01/16 12:13 PM

Post #151

Re: #150: @cjstocksup - XTNT Analyst Upgrades & Downgrades History

$XTNT 6 Months Analysis

http://www.stockta.com/cgi-bin/analysis.pl?symb=XTNT&num1=1&cobrand=windchart&mode=stock

cjstocksup PremiumMember

03/31/16 11:33 AM

Post #150

Re: #149: @cjstocksup - XTNT analyst targets ~

XTNT Analyst Upgrades & Downgrades History
Date Research Firm Action From To
Oct 16, 2008 Brean Murray Initiated Buy
Jan 28, 2008 Cowen & Co Initiated Outperform
Dec 20, 2007 Barrington Research Initiated Outperform
Apr 17, 2007 Merriman Curhan Ford Initiated Buy
Mar 21, 2007 Cowen & Co Initiated Outperform
Mar 13, 2007 Piper Jaffray Initiated Outperform
Mar 13, 2007 RBC Capital Mkts Initiated Outperform
Mar 13, 2007 Lazard Capital Initiated Buy

cjstocksup PremiumMember

03/30/16 4:38 PM

Post #149

Re: #148: @cjstocksup - XTNT HUGE FDA News Xtant Medical Announces FDA

XTNT analyst targets ~
Analyst Opinion Get Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week): 1.8
Mean Recommendation (last week): 1.8
Change: 0.0

* (Strong Buy) 1.0 - 5.0 (Sell)
Price Target Summary
Mean Target: 8.75
Median Target: 9.50
High Target: 10.00
Low Target: 6.00
No. of Brokers: 4

cjstocksup PremiumMember

03/30/16 10:12 AM

Post #148

XTNT HUGE FDA News Xtant Medical Announces FDA Clearance of the Xspan(TM) Laminoplasty Fixation System

7:30 AM ET 3/30/16 | GlobeNewswire

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary, X-spine Systems, received FDA clearance of the Xspan(TM) Laminoplasty Fixation System.

About the Xspan(TM) Laminoplasty Fixation System

The Xspan(TM) System represents the latest generation of laminoplasty fixation. Spinal laminoplasty is a surgical procedure performed to remove pressure from the spinal cord. Unlike a laminectomy, where the entire lamina is removed, only an opening or window is made on one side of the lamina to alleviate the compression of the spinal cord. The lamina is then restructured by a small plate which allows the spinal canal to increase in size without losing stability or movement in the vertebrae. This procedure can be completed at single or multiple levels.

The Xspan(TM) Laminoplasty Fixation System is intended for use in the lower cervical and upper thoracic spine (C3-T3). "We are very pleased to have received clearance for Xspan," stated Dr. David Kirschman, CSO, EVP, and Director of Xtant Medical. "This system will allow Xtant Medical to further differentiate itself from the competition and will better serve the growing needs of our surgeon partners."

Xtant Medical estimates the world wide market for laminoplasty at $110M and growing. Xspan will be available to a limited number of key surgeons in the second fiscal quarter of 2016, with a larger general release to follow later in 2016.

About Xtant Medical Holdings

Xtant Medical Holdings, Inc. (NYSE MKT:XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.

Renee

10/19/15 4:06 PM

Post #147

Re: #145: @Renee - Bacterin International Holdings Inc. changed to Xtant Medical

BONE changed to XTNT and moved to NYSE:

http://ih.advfn.com/p.php?pid=nmona&article=68935477&symbol=BONE

Lone Wolf

08/25/15 7:50 AM

Post #146

Re: #139: @MONEYMADE - WAKE UP BONE..

Might wake up today. We'll see. FDA approval of their BONE putty! OS 7millie as of July 15th. On watch bro.

Renee

08/04/15 3:58 PM

Post #145

Re: #143: @Renee - BONE delisted from AMEX to the OTC:

Bacterin International Holdings Inc. changed to Xtant Medical Holdings Inc.:

http://otce.finra.org/DLSymbolNameChanges

visal

06/03/15 8:51 AM

Post #144

news

Renee

04/09/15 4:10 PM

Post #143

BONE delisted from AMEX to the OTC:

http://otce.finra.org/DLAdditions

RealGenius Free

04/09/15 3:49 PM

Post #142

Bye, Bye!
Delisted.

djran99

04/06/15 7:46 AM

Post #141

News!

MONEYMADE

03/10/15 4:17 PM

Post #140

CONGRATS....I GUESS I'M THE ONLY BUYER HERE TODAY LOL!!!

MONEYMADE

03/10/15 7:41 AM

Post #139

Re: #138: @Transparency - BONE up over 29% and halted trading!

WAKE UP BONE..

Transparency Free

02/20/15 10:11 AM

Post #138

BONE up over 29% and halted trading!

I got out @ 3.94!!!

Transparency Free

01/29/15 10:48 PM

Post #137

BONE up almost 9.5% today!

• Solid foundation for accelerating growth in 2015 and beyond
• Growing team of Field Sales assets
• New Product Pipeline
• Path to EBITDA profitability and positive cash flow

Transparency Free

01/29/15 10:44 PM

Post #136

4th Consecutive Quarter of Year-over-Year Growth

• 3Q14 Revenues increased 6.6% over 3Q13
• Four consecutive quarters of YoY growth
• Improving Gross Profit and Gross Margins
• Narrowing Operating Loss
• Investing in New Products and Sales Assets

http://investor.bacterin.com/phoenix.zhtml?c=234008&p=irol-investorkit

Transparency Free

11/18/14 11:20 PM

Post #135

NYSE MKT Deficiency Notice (FROM THEIR LAST 10-Q, DATED 11/7/14)

On May 13, 2013, we received a deficiency notice from the NYSE MKT notifying us that we are not in compliance with Section 1003(a)(iii) of the Company Guide with stockholders’ equity of less than $6,000,000 and net losses in five of our most recent fiscal years and Section 1003(a)(ii) with stockholders’ equity of less than $4,000,000 and net losses in three of our four most recent fiscal years. On June 12, 2013 we submitted a plan to regain compliance with the continued listing requirements, and on June 21, 2013 the NYSE MKT informed us of the acceptance of our plan and gave us an extension until November 13, 2014 to regain compliance with the continued listing standards. On November 19, 2013, we received another letter from the NYSE MKT notifying us that we are not in compliance with Section 1003(a)(i) of the Company Guide with stockholders’ equity of less than $2,000,000 as of September 30, 2013 and net losses in two of three of our most recent fiscal years, and we submitted an amended plan to regain compliance. If we fail to achieve $6,000,000 in shareholder equity by the end of the extension period, our common stock will most likely be delisted from the NYSE MKT. We continue to evaluate various opportunities that may increase our shareholder equity, and we understand there is an appeal process, but as of the date of this filing, we are not in compliance with the NYSE MKT continued listing requirements, and we do not expect to achieve compliance with the NYSE MKT continued listing requirements by November 13, 2014.

https://research.scottrade.com/qnr/uploadhandler/z06a7100azaaba23eee1fd4ea880348acccd1e4f84.htm

Transparency Free

11/18/14 10:52 PM

Post #134

Bacterin Receives Delisting Notice From NYSE MKT

Bacterin Receives Delisting Notice From NYSE MKT
BELGRADE, Mont., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE) today announced that the Company received notice that the staff of NYSE Regulation, Inc. has determined to commence proceedings to delist the Company's common stock from the NYSE MKT LLC ("NYSE MKT" or the "Exchange") because the Company did not cure its non-compliance with Sections 1003(a)(i), (ii) and (iii) of the NYSE MKT Company Guide by the end of the maximum 18 month compliance plan period, which expired on November 13, 2014. Therefore, the Company's common stock is subject to delisting from the Exchange.

The Company plans to appeal the delisting determination. The Company's common stock will continue to trade on the NYSE MKT pending the appeal and final determination by the hearing panel.

Thinking-Longterm Free

11/18/14 8:29 PM

Post #133

Undervalued at current levels!!
Glad I was able to pick some shares at 3.10. They need some money at the moment, but company has a decent product and a plan to sell.

Also, some Institutional buying is expected on November 20th conference in New York. It will possibly be over $3.5 due to heavy buying by Institutions.

burnout03

10/22/14 1:46 PM

Post #132

Is this board dead or what, this is great news.

k4t4n4

09/26/14 4:50 PM

Post #131

Wow... this really took a dive. I cashed out in May (for an $18 loss). That's too bad.

maytepper

08/14/14 12:09 PM

Post #130

$BONE William Blair Maintains Outperform On Bacterin Following Solid 2Q14 Results http://www.smarteranalyst.com/2014/08/14/william-blair-maintains-outperform-on-bacterin-following-solid-2q14-results/

anotherboat12 Free

08/08/14 9:26 AM

Post #129

Re: #128: @logic_guy - BONE is gapping up huge today 78c now

When do we get the NYSE compliant PR?

logic_guy

05/06/14 10:11 AM

Post #128

BONE is gapping up huge today 78c now

logic_guy

05/05/14 11:44 AM

Post #127

Re: #126: @longtermgems - BONE has some nice technicals setting up, the

Nice one I had been BONE digging at so many levels and even more rapidly in the mid 60s

longtermgems Free

05/04/14 11:23 AM

Post #126

BONE has some nice technicals setting up, the wall street fox covers it here in this post

http://www.thewallstreetfox.com/2014/05/time-to-go-bone-digging.html

logic_guy

05/02/14 3:31 PM

Post #125

If U accumulated all these days (and still can) at various prices from 70s to 63c, you have reason to smile soon ! esp with a $1.42 high recently !

logic_guy

04/23/14 9:46 AM

Post #124

Re: #122: @logic_guy - The 63c 65c were even real nicer

BONE - looking good now
http://finance.yahoo.com/news/bacterin-announces-preclinical-results-osteoselect-113000279.html

63c must have been bottom

logic_guy

04/17/14 3:24 PM

Post #123

Re: #122: @logic_guy - The 63c 65c were even real nicer

Nice... Hoping for $1 now

logic_guy

04/14/14 1:38 PM

Post #122

The 63c 65c were even real nicer places to double down on the buys !

logic_guy

04/08/14 10:14 AM

Post #121

BONE News and Bottoming since the rise to 1.40s

http://finance.yahoo.com/news/bacterin-announces-addition-two-vice-133500062.html
Bacterin Announces the Addition of Two Vice Presidents

logic_guy

04/08/14 9:47 AM

Post #120

Re: #119: @Ichauway - BONE

Nice levels to pick up more shares below even 77/78 in last few days

Ichauway

04/04/14 5:17 PM

Post #119

Re: #118: @logic_guy - A BUY signal too for new comers

BONE

logic_guy

03/31/14 8:57 AM

Post #118

Re: #117: @Ichauway - No, Others are lurking in the shadows here.

A BUY signal too for new comers
http://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=BONE

Ichauway

03/28/14 8:37 PM

Post #117

Re: #115: @logic_guy - I thought I was all alone like a

No, Others are lurking in the shadows here.

logic_guy

03/28/14 4:06 PM

Post #116

Nice close - I guess my 0.79 and 0.80 buys are looking good so far

logic_guy

03/28/14 1:24 PM

Post #115

Re: #113: @Ichauway - Looks like BONE may be finding some support here.

I thought I was all alone like a fool at the 79c 80c level

logic_guy

03/28/14 1:23 PM

Post #114

Pl tell me this is teh day I am loaded up since 85c 83c 80c 79c etc

Ichauway

03/27/14 10:08 PM

Post #113

Looks like BONE may be finding some support here.

logic_guy

03/26/14 3:46 PM

Post #112

and the 79s

logic_guy

03/26/14 3:20 PM

Post #111

I loved the 80s even more

logic_guy

03/26/14 1:55 PM

Post #110

TU for 82s

logic_guy

03/26/14 10:47 AM

Post #109

Great give me more of those 83s

logic_guy

03/25/14 2:47 PM

Post #108

Hige Vol coming in at 0.89c

logic_guy

03/25/14 1:25 PM

Post #107

the 82 and 83s look okay so far

logic_guy

03/25/14 12:00 PM

Post #106

and some 82s

logic_guy

03/25/14 11:50 AM

Post #105

Picked up some 83s

logic_guy

03/24/14 11:08 AM

Post #104

Back to cheap levels below 90 c

logic_guy

03/20/14 7:13 PM

Post #103

Re: #101: @ospreyeye - BONE Weekly Chart: Headed for Dollar Land..........$$$[/colo

Exactly as U said

Ichauway

03/20/14 9:47 AM

Post #102

Re: #100: @Ichauway - http://stockcharts.com/c-sc/sc?s=BONE&p=D&b=5&g=0&i=t21902028947&r=13852212

BAM !

Older

Xtant Medical Holdings Inc. (XTNT)

Followers	17	Posters	45
Posts (Today)	0	Posts (Total)	151
Created	03/23/11	Type	Free
Moderators

http://www.bacterin.com/

http://finance.yahoo.com/q/ks?s=BONE+Key+Statistics

Bacterin International Holdings, Inc. develops, manufactures, and markets biologics products in the United States and internationally. The company's products are used in various applications, including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery, and subcondral bone defect repair in knee and other joint surgeries. Its biologics products include OsteoSponge, a form of demineralized bone matrix made of human bone that is used as natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC, a subchondral bone void filler and cartilage re-generation scaffold; and OsteoWrap, which wraps around non-union fractures to assist with fusion, as well as is used in conjunction with a hardware plate system, and acts as a biologic plate. The biologics products also comprise OsteoLock and BacFast facet stabilization dowels that are used to augment spinal procedures; and hMatrix dermal scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration, as well as sports, milled, and traditional allografts. The company also researches, tests, and develops coatings for medical devices, primarily antimicrobial-based coatings; and produces and distributes OsteoSelect DBM putty, an osteoinductive product used by surgeons as a bone void filler in the extremities and pelvis. In addition, it develops custom surgical instrument kits for use with allografts; and wound drain products. The company sells its products through various channels comprising independent distributors and joint development projects, as well as its direct sales network. Bacterin International Holdings, Inc. is headquartered in Belgrade, Montana.